Steven Prelack - Jun 30, 2021 Form 4 Insider Report for Aerpio Pharmaceuticals, Inc. (AADI)

Role
Director
Signature
/s/ Joseph Gardner, Attorney in Fact
Stock symbol
AADI
Transactions as of
Jun 30, 2021
Transactions value $
$18,748
Form type
4
Date filed
7/2/2021, 05:38 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Award $18.7K +12.3K +101.51% $1.52 24.5K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021.